The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Abu-Ghazaleh and Sana Pharmaceutical Sign MoU for the Implementation of the European Quality Mark

15-Mar-2017 | Source : AG-IP News | Visits : 5256
Special to ag-IP-news Agency

AMMAN - Talal Abu-Ghazaleh & Co. Consulting (TAG-Consult) for Quality Management Systems and Sana Pharmaceutical Industries signed a cooperation agreement for the preparation and application of CE Marking (the European quality mark) under the supervision and with the funding of the European Bank for Reconstruction and Development (EBRD). 

The agreement is considered the first of its kind in the field of management system consulting services provided by Talal Abu-Ghazaleh Organization (TAG-Org); it involves the preparation of technical files for the products that are globally classified as medical devices.

The agreement provides for the preparation and application of a quality management system in order to obtain the European CE Marking, by focusing on the preparation of technical files that meet CE marking requirements. The project is expected to be completed in May 2017.

TAG-Org was established in 1972. It is the largest global group of professional services in various fields, and operates through its 86 offices and 150 representational offices worldwide.

TAG-Consult for Quality Management Systems (QMSs) is one of TAG-Org companies. It is specialized in the preparation of various management and quality systems such as IOS 9001:2015, ISO 14001:2015, OHSAS 18001:2007, food industry systems, pharmaceutical industry systems, systems in the field of aviation, etc…
TAG-Consult has implemented many projects for companies, profit and non-profit organizations, government institutions, and educational institutions among others. 

SANA Pharma is a multidisciplinary research company with a broad spectrum of research lines, services and manufacturing site for dermatological products.
The company was established by a group of qualified people having extensive knowledge and experience in research and development in pharmaceutical industry, in close cooperation with academic and research institution.
The company is focusing on developing, manufacturing and marketing innovative healthcare products based on evidence of clinical significance and scientific knowledge. Sana pharma has state of the art manufacturing site for liquid and semisolid preparation approved by JFDA for manufacturing medicated cosmetic, medical devise and herbal products. Sana pharma is also active in the area of technology transfer of different pharmaceutical products in MENA region and EU countries.

Related Articles